Groowe Groowe / Newsroom / PFE
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

PFE News

Pfizer Inc.

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

prnewswire.com
SMWB PFE ICE

ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP

globenewswire.com
PRZO PFE

LexisNexis Recognizes Visionary Companies From 18 Countries as “Top 100 Global Innovators” for 2026

globenewswire.com
IBM ADI AMAT AVGO CDNS CSCO DELL GOOG INTC MRVL MSFT NVDA QCOM AMD TXN ADPT LRCX MU SNPS AMGN BMY GILD LLY MRK PFE REGN TEVA VRTX ACGL DOW ECL HON LMT MMM NEE RTX UNH XOM INTU MCHP IP

LexisNexis Recognizes Visionary Companies From 18 Countries as “Top 100 Global Innovators” for 2026

globenewswire.com
IBM ADI AMAT AVGO CDNS CSCO DELL INTC LRCX MRVL MU NVDA QCOM SNPS TXN AMD LLY MRNA BMY GILD PFE JNJ ABBV AMGN BIIB REGN VRTX ADSK GOOG MSFT ORCL CRM ADPT ALGN BKR CTAS DDOG DXCM EXPE FIVN FTNT IDXX ILMN INTU ISRG JD KDP LULU MCHP MDLZ MELI MNST NFLX NOW NTES OKTA ON PANW PAYX PDD PEP PYPL ROKU SBUX SMCI SWKS TEAM TCOM TDS TER TGT TTEC TTWO TWLO ULTA VRSK WDC WEC XRAY ZBRA ZM ASML KLAC NXPI AMZN AAPL GOOGL META TSLA Z KHC CL PG COST WMT

Hematologic Malignancies Market to Reach USD 128.48 Billion by 2032, Driven by Immunotherapy, CAR-T, and Precision Oncology - Credence Research Inc.

prnewswire.com
GILD PFE MRK

Suzanne Nora Johnson Joins Wellcome Leap Board of Directors

globenewswire.com
GS PFE INTU

Suzanne Nora Johnson Joins Wellcome Leap Board of Directors

globenewswire.com
GS PFE INTU

Hot Springs Arkansas Neurologist Kara Way Opens New Way Neurology

globenewswire.com
PFE

AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0

globenewswire.com
PFE MRNA NVS MRK SNY

AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0

globenewswire.com
PFE MRNA NVS MRK SNY